OrbiMed’s Abbott ABT Stock Holding History

OrbiMed’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-715,100	Closed	-$62.1M	–	143
2019 Q4	$62.1M	Sell	715,100 -107,300	-13%	-$8.99M	0.89%	39
2019 Q3	$68.8M	Sell	822,400 -115,600	-12%	-$9.82M	1.31%	27
2019 Q2	$78.9M	Buy	938,000 +322,600	+52%	+$25.4M	1.22%	26
2019 Q1	$49.2M	Buy	615,400 +167,000	+37%	+$12.4M	0.76%	40
2018 Q4	$32.4M	Buy	448,400 +54,300	+14%	+$3.82M	0.6%	53
2018 Q3	$28.9M	Hold	394,100	–	–	0.35%	74
2018 Q2	$24M	Hold	394,100	–	–	0.29%	82
2018 Q1	$23.6M	Buy	+394,100	New	+$23.7M	0.29%	76
2017 Q1	–	Sell	-245,400	Closed	-$9.43M	–	137
2016 Q4	$9.43M	Sell	245,400 -195,100	-44%	-$7.74M	0.12%	94
2016 Q3	$18.6M	Buy	440,500 +203,500	+86%	+$8.72M	0.21%	76
2016 Q2	$9.32M	Hold	237,000	–	–	0.1%	94
2016 Q1	$9.91M	Buy	237,000 +26,000	+12%	+$1.03M	0.1%	95
2015 Q4	$9.48M	Hold	211,000	–	–	0.09%	93
2015 Q3	$8.49M	Hold	211,000	–	–	0.09%	97
2015 Q2	$10.4M	Hold	211,000	–	–	0.09%	103
2015 Q1	$9.78M	Hold	211,000	–	–	0.08%	106
2014 Q4	$9.5M	Buy	211,000 +31,000	+17%	+$1.35M	0.09%	96
2014 Q3	$7.49M	Hold	180,000	–	–	0.08%	105
2014 Q2	$7.36M	Buy	180,000 +6,000	+3%	+$236K	0.09%	97
2014 Q1	$6.7M	Sell	174,000 -131,000	-43%	-$5.05M	0.08%	107
2013 Q4	$11.7M	Sell	305,000 -95,000	-24%	-$3.5M	0.17%	78
2013 Q3	$13.3M	Sell	400,000 -80,000	-17%	-$2.81M	0.24%	66
2013 Q2	$16.7M	Buy	+480,000	New	+$17.6M	0.35%	58

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

OrbiMed's ABT Position: Q1 2020 in Review

OrbiMed sold out of Abbott (ABT) in Q1 2020, closing a stake of 715,100 shares — an estimated $62.1M sold.

OrbiMed first reported a position in ABT in Q2 2013 and held it in 23 quarters. The position peaked at $78.9M in Q2 2019. 2,145 funds tracked by Wall St. Rank hold ABT as of Q1 2020.

OrbiMed reported no remaining Abbott position as of Q1 2020 after selling out during the quarter.
OrbiMed sold 715,100 Abbott shares in Q1 2020, an estimated $62.1M.
OrbiMed first reported a position in Abbott in Q2 2013 and held it in 23 quarters.
OrbiMed's Abbott position peaked at $78.9M in Q2 2019.
2,145 funds tracked by Wall St. Rank held Abbott as of Q1 2020.

Based on OrbiMed's 13F filing for Q1 2020, filed 15 May 2020.